Finland pharmacy closures are rising to an unusually high level this year, with pharmacies shutting down across both large cities and small municipalities after changes to medicine pricing and pharmacy taxation. According to data obtained by Yle from the Finnish Medicines Agency Fimea, ten pharmacies have already closed or are expected to close in 2026, after seven closures last year.
Where Finland’s record pharmacy closures are happening
The closures are spread across the country rather than concentrated in one region. Fimea’s figures show that one pharmacy in Helsinki is expected to close soon, while closures have already affected places such as Jyväskylä, Luhanka, Rovaniemi and Pieksämäki.
In Central Finland, one pharmacy has closed in Huhtasuo, a district of Jyväskylä, a city of around 150,000 residents. Another has closed in Luhanka, a municipality with fewer than 700 people. Other pharmacies that closed this year or last year were located near urban centres in Rovaniemi and Pieksämäki.
The numbers are unusual by recent Finnish standards. Over the past decade, the country has normally seen no more than two or three pharmacy closures a year. The seven closures recorded in 2025 and the ten already known for 2026 therefore mark a clear acceleration.
Why branch pharmacies are under pressure
So far, all the pharmacies closed last year, closed this year or already known to Fimea as upcoming closures are branch pharmacies. In Finland, a pharmacist may operate a main pharmacy and between one and three branch pharmacies elsewhere.
For customers, the difference between a main pharmacy and a branch pharmacy may not always be visible. But the closure of a local branch can still weaken access to medicines and pharmaceutical advice, especially in smaller communities where alternative services may be several kilometres away.
The Association of Finnish Pharmacies has linked the closures to government decisions that came into force at the start of the year. These include a reduction in the medicine tariff for prescription drugs, which lowered the margin pharmacies receive from medicines, as well as tighter pharmacy taxation and changes to the taxation of branch pharmacies.
Finland’s pharmacy sector is strongly regulated. Pharmacists operate as private entrepreneurs, but they cannot freely set medicine prices. Prices are determined nationally through the medicine tariff, and pharmacies need authorisation from Fimea to operate both main pharmacies and branch pharmacies.
A small pharmacy can depend on local health services
The case of Pylkönmäki in Central Finland shows how fragile the economics of local pharmacy services can be. Pharmacist Kirsi Levijoki runs her main pharmacy in Karstula, a municipality of around 3,500 residents, and a branch pharmacy in Pylkönmäki, which has around 850 residents.
Levijoki told Yle that the government’s savings measures have not yet affected the profitability of her own pharmacies. She said pharmacies differ significantly in their sales structure, while acknowledging that the changes are already affecting some colleagues more strongly.
Her Pylkönmäki branch, however, has been unprofitable for several years. In that case, the broader local welfare structure appears to matter more than the latest pharmacy tax changes. The Central Finland wellbeing services county has closed a care home in Pylkönmäki, reducing local demand and increasing the pharmacy’s losses.
Even when a branch pharmacy is unprofitable, the pharmacist cannot simply decide to close it. A closure requires permission from Fimea, because pharmacy licences are intended to secure access to medicines across the country.
Over-the-counter medicine sales could change the market again
Finland’s pharmacy network may face further pressure from next year. From 2027, grocery stores and other retail businesses will be able to apply for licences to sell a limited selection of over-the-counter medicines outside pharmacies.
The reform is intended to expand access to low-risk non-prescription medicines, but it has raised concern in the pharmacy sector. Over-the-counter products are often more profitable for pharmacies than prescription medicines, because margins on prescription drugs are more tightly controlled.
For smaller branch pharmacies, losing part of that business could make an already fragile model harder to sustain. This is why the current closures are not only a local service issue, but also part of a wider debate about how Finland balances medicine accessibility, public savings and the financial viability of regulated health services.
The trend also fits into a broader Nordic question: how to preserve essential services outside major urban centres while public authorities seek lower costs and more flexible retail models. In Finland, the next test will be whether pharmacy closures remain an exceptional spike or become the first visible sign of a deeper restructuring of local healthcare access.
